Tirzepatide represents a groundbreaking therapeutic agent for individuals facing type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://donnanbdk727338.blogaritma.com/38495369/tirzepatide-a-game-changer-for-type-2-diabetes